1989
DOI: 10.1016/s0021-9258(18)81795-1
|View full text |Cite
|
Sign up to set email alerts
|

Non-carrier-mediated uptake of the mannosidase I inhibitor 1-deoxymannojirimycin by K562 erythroleukemic cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

1990
1990
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(3 citation statements)
references
References 29 publications
1
2
0
Order By: Relevance
“…5 b, incubation of T. cruzi cells with DNJ concentrations up to 23-fold higher than those of [14C]glucose for 2 min did not affect incorporation of label into hot 10% trichloroacetic acid insoluble material (mainly amino acids in proteins). This last result also strongly suggested that the inhibitors entered T. cruzi cells by facilitated diffusion and not through an hexose transporter, the same as has been reported to occur for the mannose analog 1-deoxymannojirimycin in mammalian cells (27). Nevertheless, the cruzipain total content of lysosomes was partially affected by the drug: as shown in Fig.…”
Section: N J Does Not Affect T Cruzi Cell Growth Rate or The Parasite General Metabolism But Partially Affects Cruzipain Synthesis And Thsupporting
confidence: 79%
“…5 b, incubation of T. cruzi cells with DNJ concentrations up to 23-fold higher than those of [14C]glucose for 2 min did not affect incorporation of label into hot 10% trichloroacetic acid insoluble material (mainly amino acids in proteins). This last result also strongly suggested that the inhibitors entered T. cruzi cells by facilitated diffusion and not through an hexose transporter, the same as has been reported to occur for the mannose analog 1-deoxymannojirimycin in mammalian cells (27). Nevertheless, the cruzipain total content of lysosomes was partially affected by the drug: as shown in Fig.…”
Section: N J Does Not Affect T Cruzi Cell Growth Rate or The Parasite General Metabolism But Partially Affects Cruzipain Synthesis And Thsupporting
confidence: 79%
“…Because MVBs continuously receive input of new membranes and sort cargoes toward diverse fates, notably including lysosomal proteolysis, we tested whether biosynthesis or degradation of GFP-CD63 contributes to the GFP decay measured during the time frame of our microscopy assay. A pulse-chase experiment with 1-deoxymannosidase I (DMM), an inhibitor of mannosidase I, 12 was used to assess the relative proportion of old GFP-CD63 bearing long polylactosaminoglycans versus newly synthesized GFP-CD63 carrying high-mannose N-linked glycans (migrating at a lower molecular weight on the gel) over time ( Figure 2 G), yielding a half-life longer than 24 h ( Figure 2 H), which was expected because CD63 is known to be highly stable. 13 These data indicate that the natural turnover of GFP-CD63 does not significantly contribute to the decay of endolysosomal GFP fluorescence following dimerizer addition.…”
Section: Resultsmentioning
confidence: 99%
“…The concentrations of inhibitors in the growth medium were, therefore, 300-1500-fold higher than the I50 values. It is unknown whether the concentrations found in the lumen of the endoplasmic reticulum (where presumably glucosidase II is located) are similar to those of the external milieu, but it has been determined that deoxymannojirimycin (and probably DNJ) does not penetrate into mammalian cells through the hexose transporter but penetrates through facilitated diffusion (Neefjes et al, 1989). The fact that a 20-25-fold molar excess of DNJ or CNS over that of glucose did not interfere with the incorporation of label into trichloroacetic acid insoluble material suggests that the inhibitors and glucose penetrate into T. cruzi cells by different mechanisms.…”
Section: Discussionmentioning
confidence: 99%